16 April 2012: The Biosafety Advisory Council issues a positive advice (with conditions) for this trial.
Trial reference:
Evaluation of the safety and efficacy of the vaccine PB-116 in the control of porcine pleuropneumonia caused by Actinobacillus pleuropneumoniae